Related Reports
Global Report
The global anti-VEGF therapeutics market size was valued at USD 12.3 billion in 2022. It is estimated to reach USD 13.7 billion by 2031, growing at a CAGR of 0.6% during the forecast period (2023–2031).
The human body naturally produces VEGF,
Buy Now
Global Report
The global cervical cancer therapeutics market size was valued at USD 5.80 billion in 2022. It is estimated to reach USD 8.59 billion by 2031, growing at a CAGR of 4.47% during the forecast period (2023–2031).
The cells of the cervix, or
Buy Now
Global Report
Leukemia therapeutics are therapies used for treating leukemia at different levels. The earlier cancer is diagnosed and treated, the better the chance of its being cured. The game-changing technological advancements in the treatment of cancer are con
Buy Now
Global Report
The global multiple myeloma therapeutics market size was valued at USD 23.27 billion in 2021, and it is anticipated to reach USD 39.65 billion by 2030 at a CAGR of 6.1%. Multiple myeloma is a blood malignancy that affects plasma cells in the bone mar
Buy Now
Global Report
Pneumonia is a prevalent form of an acute respiratory infection that affects the alveoli of the lungs. Fungi, bacteria cause the disease, or viruses mediated infection. When an individual has pneumonia, the clinical manifestations can be as severe as
Buy Now